FYB-206 is under development for the treatment of malignant melanoma (black skin cancer) and non-small cell lung cancer. The drug candidate is a pembrolizumab biosimilar. It acts by targeting ...

CX-801 is under development for the treatment of metastatic solid tumors including metastatic melanoma, metastatic renal cell carcinoma (RCC) and head and neck squamous cell carcinoma (HNSCC). It is a ...

With breakthroughs from melanoma to pancreatic cancer, this has been a year of great promise in the field of cancer vaccines.

The Jimmy Carter drug introduced the world to cancer immunotherapy, a treatment that differs from chemotherapy. Carter was ...

While his cause of death has not been confirmed, one possibility is skin cancer. Carter battled with Stage 4 melanoma in 2015 ...

Researchers at the University of Queensland are making significant strides toward developing a groundbreaking topical cream ...

The FDA approved several drugs in December for the treatment of diseases including pancreatic adenocarcinoma, lung cancer, ...

The following is a summary of “Unbiased Drug Target Prediction Reveals Sensitivity to Ferroptosis Inducers, HDAC and RTK Inhibitors in Melanoma Subtypes,” published in the December 2024 issue of ...

Carter’s successful cancer treatment “would have been considered ... In 2015, a person with metastatic melanoma — a form of skin cancer that has spread throughout the body — was unlikely ...